WALTHAM, Mass and DUBLIN, May 03, 2024 Mural Oncology plc , a clinical-stage immuno-oncology company leveraging its core competencies in immune cell modulation and protein engineering to develop.
WALTHAM, Mass. and DUBLIN, Ireland, April 24, 2024 Mural Oncology plc , a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed to.
24.04.2024 - WALTHAM, Mass. and DUBLIN, Ireland, April 24, 2024 (GLOBE NEWSWIRE) - Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed to address areas of unmet .
Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
AACR: Mural debuts data for potential pipeline additions fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.